BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27631986)

  • 1. Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females.
    Hall OJ; Limjunyawong N; Vermillion MS; Robinson DP; Wohlgemuth N; Pekosz A; Mitzner W; Klein SL
    PLoS Pathog; 2016 Sep; 12(9):e1005840. PubMed ID: 27631986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of amphiregulin and recovery from influenza is greater in males than females.
    Vermillion MS; Ursin RL; Kuok DIT; Vom Steeg LG; Wohlgemuth N; Hall OJ; Fink AL; Sasse E; Nelson A; Ndeh R; McGrath-Morrow S; Mitzner W; Chan MCW; Pekosz A; Klein SL
    Biol Sex Differ; 2018 Jul; 9(1):24. PubMed ID: 30012205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.
    Robinson DP; Hall OJ; Nilles TL; Bream JH; Klein SL
    J Virol; 2014 May; 88(9):4711-20. PubMed ID: 24522912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
    Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
    J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21R signaling suppresses IL-17+ gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after Influenza A virus infection.
    Moser EK; Sun J; Kim TS; Braciale TJ
    PLoS One; 2015; 10(4):e0120169. PubMed ID: 25849970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
    Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
    J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.
    Dhakal S; Loube J; Misplon JA; Lo CY; Creisher PS; Mulka KR; Deshpande S; Mitzner W; Klein SL; Epstein SL
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33627390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor signaling in the lungs mitigates inflammation and improves the outcome of influenza in mice.
    Vom Steeg LG; Dhakal S; Woldetsadik YA; Park HS; Mulka KR; Reilly EC; Topham DJ; Klein SL
    PLoS Pathog; 2020 Jul; 16(7):e1008506. PubMed ID: 32645119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.
    Huang L; Li L; Klonowski KD; Tompkins SM; Tripp RA; Mellor AL
    PLoS One; 2013; 8(6):e66546. PubMed ID: 23785507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    Huang S; Zhu B; Cheon IS; Goplen NP; Jiang L; Zhang R; Peebles RS; Mack M; Kaplan MH; Limper AH; Sun J
    J Virol; 2019 May; 93(9):. PubMed ID: 30787149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection.
    Strickland DH; Fear V; Shenton S; Wikstrom ME; Zosky G; Larcombe AN; Holt PG; Berry C; von Garnier C; Stumbles PA
    PLoS One; 2014; 9(11):e111520. PubMed ID: 25398128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar Type II Epithelial Cells Contribute to the Anti-Influenza A Virus Response in the Lung by Integrating Pathogen- and Microenvironment-Derived Signals.
    Stegemann-Koniszewski S; Jeron A; Gereke M; Geffers R; Kröger A; Gunzer M; Bruder D
    mBio; 2016 May; 7(3):. PubMed ID: 27143386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.
    Egarnes B; Gosselin J
    Front Immunol; 2018; 9():132. PubMed ID: 29445379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.
    Kok WL; Denney L; Benam K; Cole S; Clelland C; McMichael AJ; Ho LP
    J Leukoc Biol; 2012 Mar; 91(3):357-68. PubMed ID: 22003207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.
    Antunes I; Kassiotis G
    J Virol; 2010 Dec; 84(24):12564-75. PubMed ID: 20943986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.
    Zacharias ZR; Ross KA; Hornick EE; Goodman JT; Narasimhan B; Waldschmidt TJ; Legge KL
    Front Immunol; 2018; 9():1953. PubMed ID: 30233573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection.
    Sohail A; Iqbal AA; Sahini N; Chen F; Tantawy M; Waqas SFH; Winterhoff M; Ebensen T; Schultz K; Geffers R; Schughart K; Preusse M; Shehata M; Bähre H; Pils MC; Guzman CA; Mostafa A; Pleschka S; Falk C; Michelucci A; Pessler F
    PLoS Pathog; 2022 Jan; 18(1):e1010219. PubMed ID: 35025971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.